FDA Clears Sentient’s Tixel for Treatment of Periorbital Wrinkles
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
As 2025 begins, key trends in aesthetic medicine focus on advancements such as preservation rhinoplasty, personalized body contouring, facial optimization for the digital age, enhanced recovery techniques, and preventative treatments designed to deliver natural results and improve patient outcomes.